Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: Immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy

Virology

Volumn 452-453, Issue , 2014, Pages 152-157

  Teijaro, John R ^a   Walsh, Kevin B ^a,f   Long, James P ^b   Tordoff, Kevin P ^b   Stark, Gregory V ^b   Eisfeld, Amie J ^c   Kawaoka, Yoshihiro ^c,d,e   Rosen, Hugh ^a   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f GENENTECH INC   (United States)

Author keywords

Ferrets; H1N1 influenza; Oseltamivir; Pathogenesis; RP 002; S1P1 Rec agonist

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR; RP 002; SPHINGOSINE 1 PHOSPHATE 1 RECEPTOR AGONIST; UNCLASSIFIED DRUG;

2009 H1N1 INFLUENZA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FERRET; HISTOPATHOLOGY; IMMUNOPATHOLOGY; INFECTION CONTROL; INFLUENZA VIRUS A H1N1; LUNG INJURY; MALE; NONHUMAN; PRIORITY JOURNAL;

FERRETS; H1N1 INFLUENZA; OSELTAMIVIR; PATHOGENESIS; RP-002; S1P1 REC AGONIST;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; FERRETS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LUNG; MALE; RECEPTORS, LYSOSPHINGOLIPID;

EID: 84893419348     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.01.003     Document Type: Article

References (13)

1. Belser J.A., Katz J.M., Tumpey T.M. The ferret as a model organism to study influenza A virus infection. Dis. Models Mech. 2011, 4(5):575-579.
2. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y., Hatta M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460(7258):1021-1025.
3. Kawashima H., Kashiwagi Y., Ioi H., Morichi S., Oana S., Yamanaka G., et al. Production of chemokines in respiratory syncytial virus infection with central nervous system manifestations. J. Infect. Chemother.: Off. J. Jpn. Soc. Chemother. 2012, 18(6):827-831.
4. Macneil A., Nichol S.T., Spiropoulou C.F. Hantavirus pulmonary syndrome. Virus. Res. 2011, 162(1-2):138-147.
5. Maher J.A., DeStefano J. The ferret: an animal model to study influenza virus. Lab Anim. 2004, 33(9):50-53.
6. Marsolais D., Hahm B., Walsh K.B., Edelmann K.H., McGavern D., Hatta Y., et al. A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(5):1560-1565.
7. Poon L.L., Mak P.W., Li O.T., Chan K.H., Cheung C.L., Ma E.S., et al. Rapid detection of reassortment of pandemic H1N1/2009 influenza virus. Clin. Chem. 2010, 56(8):1340-1344.
8. Shieh W.J., Blau D.M., Denison A.M., Deleon-Carnes M., Adem P., Bhatnagar J., et al. Pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am. J. Pathol. 2009, 177(1):166-175.
9. Smith H., Sweet C. Lessons for human influenza from pathogenicity studies with ferrets. Rev. Infect. Dis. 1988, 10(1):56-75.
10. Teijaro J.R., Walsh K.B., Cahalan S., Fremgen D.M., Roberts E., Scott F., et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011, 146(6):980-991.
11. Thiel V., Weber F. Interferon and cytokine responses to SARS-coronavirus infection. Cytokine Growth Factor Rev. 2008, 19(2):121-132.
12. Vijaykrishna D., Poon L.L., Zhu H.C., Ma S.K., Li O.T., Cheung C.L., et al. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 2010, 328(5985):1529.
13. Walsh K.B., Teijaro J.R., Wilker P.R., Jatzek A., Fremgen D.M., Das S.C., et al. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(29):12018-12023.